Target Name: LOC105374860
NCBI ID: G105374860
Review Report on LOC105374860 Target / Biomarker Content of Review Report on LOC105374860 Target / Biomarker
LOC105374860
Other Name(s): Uncharacterized LOC105374860 | uncharacterized LOC105374860 | Uncharacterized protein LOC105374860

LOC105374860: A Potential Drug Target and Biomarker

LOC105374860 is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. Its unique sequence and structure have caught the attention of researchers, who are investigating its potential role in various diseases. While more research is needed, the findings of some studies have led to the possibility that LOC105374860 could be a drug target or biomarker.

The Protein Structure and Function

LOC105374860 is a member of the LOC105 family, which includes several proteins that share similar sequences and structures. These proteins are known as small GTPases, which are a type of protein that uses guanosine triphosphate (GTP) to regulate various cellular processes. The LOC105 family is characterized by the presence of a unique catalytic domain, which is responsible for the protein's ATP-dependent catalytic activity.

LOC105374860 is expressed in a variety of tissues and cells throughout the body, including the brain, heart, liver, and kidneys. It has been shown to be involved in various physiological processes, including the regulation of ion and water transport, cell signaling, and inflammation.

Potential Drug Target

The unique structure and function of LOC105374860 have led some researchers to consider its potential as a drug target. One of the main reasons for this is the protein's ATP-dependent catalytic activity, which could make it an attractive target for small molecule inhibitors. These inhibitors could potentially disrupt the protein's function and lead to the inhibition of cellular processes that are necessary for the disease.

Another potential mechanism by which LOC105374860 could be targeted is its role in cell signaling. The LOC105 family has been shown to play a role in various signaling pathways, including the regulation of cell growth, differentiation, and survival. By targeting LOC105374860, researchers could potentially disrupt these signaling pathways and lead to the inhibition of cellular processes that are necessary for the disease.

Biomarker

LOC105374860 may also be potential biomarker for some diseases. The protein is expressed in various tissues and cells throughout the body, which could make it an attractive target for diagnostic tests. For example, the expression of LOC105374860 has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Additionally, the protein's unique structure and function have led some researchers to consider its potential as a therapeutic target for small molecule inhibitors. By using small molecule inhibitors to target LOC105374860, researchers could potentially disrupt its function and lead to the inhibition of cellular processes that are necessary for the disease.

Conclusion

LOC105374860 is a protein that has caught the attention of researchers due to its unique structure and function. While more research is needed, the findings of some studies suggest that LOC105374860 could be a drug target or biomarker for various diseases. Further research is needed to fully understand its potential role in the disease.

Protein Name: Uncharacterized LOC105374860

The "LOC105374860 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374860 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623